Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Connecticut for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Connecticut only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Connecticut (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

James Weisz (NPI 1639144967)

Field	Value
Entity Type	Individual
Organization	James Weisz
Address	46 Prince St
City	New Haven
State	CT
ZIP	06519
Taxonomy	Ophthalmology Physician
NPI Enumerated	February 21, 2006

Payer Source	Total Paid
Medicare	$1.3M
Medicaid	$0

Key Findings

This provider is effectively single‑payer in publicly reported claims: Total Medicare revenue is $1.3M while there is no Medicaid billing on file. That concentration means analyses of patient mix and reimbursement should focus on Medicare fee‑for‑service dynamics rather than state Medicaid contracting or utilization patterns.

Revenue is highly concentrated in a small set of intravitreal drug codes: the precomputed top 3 Medicare codes (J0178, J2777, J3490) account for 79.9% of this provider's total Medicare revenue. In particular, J0178 alone represents $627.4K (48.1%) and J2777 represents $315.8K (24.2%), marking the practice as materially dependent on intraocular drug administration.

The CPT/HCPCS mix points to a retina‑focused ophthalmology practice that emphasizes frequent intravitreal injections and retinal imaging. High‑revenue drug codes such as J0178 (920 claims, $682 avg paid/claim, $627.4K) and J2777 (11.3K claims, $28 avg paid/claim, $315.8K) combined with procedure code 67028 (730 claims, $102 avg paid/claim, $74.5K) indicate day‑to‑day procedural throughput centered on medication delivery into the vitreous.

On competitive standing for major drugs, this provider appears to be a modest national participant rather than a dominant outlier: J0178 ranks #1366 of 3204 providers nationally (57th percentile; typical, unremarkable volume), J2777 ranks #919 of 2039 (55th percentile; typical, unremarkable volume), and J3490 ranks #1503 of 2838 (46th percentile; typical, unremarkable volume). Those ranks signal routine participation in anti‑VEGF and related drug administration cohorts rather than leadership in those markets.

A notable statistical outlier within the service mix is retinal imaging: 92134 (1.4K claims, $32 avg paid/claim, $44.3K) ranks #1662 of 26868 providers nationally (94th percentile; notably above typical national volume). This suggests the practice is comparatively high‑volume for OCT/retinal imaging relative to peers, supporting the clinical intensity implied by the injection volumes.

The provider shows adoption of newer intravitreal therapies but without leading national share: J2777 (faricimab) has a very large claim count (11.3K claims, $315.8K) with a low avg paid/claim ($28), while J2781 (pegcetacoplan) appears at 435 claims and $52.2K (4.0%); J2781 ranks #311 of 490 providers nationally (34th percentile; typical, unremarkable volume). This pattern is consistent with offering cutting‑edge retinal agents as part of routine care rather than operating as an early national adopter with outsized market share.

Routine office and exam codes contribute relatively small shares of Medicare revenue compared with drug and imaging services: 92012 (596 claims, $42.3K, 3.2%), 92014 (299 claims, $28.7K, 2.2%), and 99204 (83 claims, $10.5K, 0.8%) each represent single‑digit percentages of total Medicare revenue. That distribution indicates revenue and operational capacity are weighted toward procedure/drug throughput rather than E&M volume.

The provider has long tenure in the NPI file (enumerated 2006-02-21 (~20 years ago)), which aligns with an established outpatient ophthalmology practice focused on intravitreal treatments and retinal diagnostics. Combined with the Medicare‑only billing picture, this tenure suggests a stable, mature clinical operation whose public claims reflect sustained procedural and imaging activity rather than transient billing patterns.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

12 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	920	$680	$627.4K
J2777	Injection, faricimab‑svoa, 0.1 mg	11,280	$30	$315.8K
J3490	Unclassified drugs	50	$1,820	$98.3K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	730	$100	$74.5K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	440	$120	$52.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,380	$30	$44.3K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	600	$70	$42.3K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	300	$100	$28.7K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	80	$130	$10.5K
J9035	Injection, bevacizumab, 10 mg	130	$50	$6.6K

Showing 1–10 of 12

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 12 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Connecticut Distribution

James Weisz — 0 of 12 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Connecticut

Full comparison — all codes billed, vs. state median

12 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	19	40	830	$690	$713.1K
J2777	12	30	8,190	$30	$340.4K
J3490	8	20	50	$1,380	$76K
67028	21	50	540	$100	$66.4K
J2781	6	10	440	$120	$55.7K
92014	127	580	100	$90	$18.6K
92012	28	300	120	$70	$15.2K
J9035	16	30	130	$50	$10.4K
92134	18	320	60	$30	$7.7K
99204	212	2,660	30	$120	$4.6K

Showing 1–10 of 12

Related Providers

Other providers that share a Tax Identification Number (TIN) with James Weisz, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Connecticut Retina Consultants LLC	CT	Ophthalmology Physician	$0	$8.3M
Wayne Larrison	CT	Ophthalmology Physician	$1.9M	$0
Nancy Miller-rivero	NY	Retina Specialist (Ophthalmology) Physician	$1.4M	$0
Matthew Dombrow	CT	Ophthalmology Physician	$1M	$0
Meredith Gershon	CT	Ophthalmology Physician	$834.7K	$0
Richard Kaplan	CT	Ophthalmology Physician	$800.1K	$0
Aaron Steen	CT	Dermatology Physician	$364.3K	$0
Andrew Herbst	CT	MOHS-Micrographic Surgery Physician	$333.9K	$0
Jason Mayo	CT	Diagnostic Radiology Physician	$267.4K	$0
Christopher Lynch	CT	Adult Reconstructive Orthopaedic Surgery Physician	$264K	$0

Nearby Providers

Other providers in the same ZIP code as James Weisz, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Cornell Scott Hill Health Corporation	CT	Federally Qualified Health Center (FQHC)	$338.5K	$294.2M
Apt Foundation, Inc	CT	Methadone Clinic	$0	$28.6M
Yale Univ School Of Medicine	CT	Adolescent and Children Mental Health Clinic/Center	$0	$13.2M
New Haven Board Of Education	CT	Local Education Agency (LEA)	$0	$12.2M
Continuum Of Care, Inc.	CT	Adult Mental Health Clinic/Center	$0	$4.9M
Connecticut Pulmonary Specialists, PC	CT	Pulmonary Disease Physician	$0	$2.3M
Rachel Collins	CT	Professional Counselor	$0	$1.7M
Amir Cohen	CT	Ophthalmology Physician	$1.1M	$0
Robert Wiznia	CT	Ophthalmology Physician	$228.5K	$644.2K
Michael Imevbore	CT	Pulmonary Disease Physician	$412.4K	$0

James Weisz — Billing Profile & Reimbursement Data

Sign up for James Weisz — Billing Profile & Reimbursement Data policy alerts

James Weisz — Billing Profile & Reimbursement Data

Sign up for James Weisz — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References